ℹ️
🇬🇧
Search
Search for people relevant for "alzheimers-disease"
alzheimers-disease
Person
Class
Person
Publication
Programmes
Export current view
PharmDr. Vendula Šepsová Ph.D.
External academic staff at Faculty of Pharmacy in Hradec Králové
29 publications
Publications
publication
Structure-Guided Design of N-Methylpropargylamino- Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's Disease
2023 |
Faculty of Science, Faculty of Pharmacy in Hradec Králové
publication
Tacrine - Benzothiazoles: Novel class of potential multitarget anti-Alzheimer's drugs dealing with cholinergic, amyloid and mitochondrial systems
2021 |
Central Library of Charles University, Faculty of Medicine in Hradec Králové
publication
Huprine Y-Tryptophan heterodimers with potential implication to Alzheimer's disease treatment
2021 |
Faculty of Pharmacy in Hradec Králové, First Faculty of Medicine
publication
Tacrine and its 7-methoxy derivate; time-change concentration in plasma and brain tissue and basic toxicological profile in rats
2021 |
Faculty of Medicine in Hradec Králové
publication
Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease
2021 |
Publication without faculty affiliation
publication
Design and synthesis of novel tacrine-indole hybrids as potential multitarget-directed ligands for the treatment of Alzheimer's disease
2021 |
Publication without faculty affiliation
publication
Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease
2019 |
Central Library of Charles University, Faculty of Medicine in Hradec Králové
publication
Exploring structure-activity relationship in tacrine-squaramide derivatives as potent Cholinesterase inhibitors
2019 |
Publication without faculty affiliation
publication
The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease
2018 |
Faculty of Pharmacy in Hradec Králové
publication
Design, synthesis, and biological evaluation of 1-benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-Alzheimer's agents
2018 |
Publication without faculty affiliation
Load more publications (19)
Loading network view...